Summary

Eligibility
for people ages 18 years and up (full criteria)
Location
at Orange, California
Dates
study started
completion around
Principal Investigator
by Misako Nagasaka

Description

Summary

This is a pilot study collecting data on the diversity and composition of gut microbiomes in subjects with advanced/metastatic Non-Small Cell Lung Cancer (NSCLC) while receiving treatment for NSCLC.

Official Title

A Pilot Study to Assess the Diversity of Gut Microbiome in Metastatic Non-Small Cell Lung Cancer (NSCLC) in Correlation to Treatment Effects and Adverse Effects

Keywords

Non Small Cell Lung Cancer, Lung Neoplasms, Non-Small-Cell Lung Carcinoma, Microbiome

Eligibility

You can join if…

Open to people ages 18 years and up

    1. Advanced/Metastatic non-small cell lung cancer NSCLC patients.
    1. The patient himself/herself must be 18 years of age on day of signing informed consent.
    1. The subject has signed the informed consent form.
    1. The patient must be eligible to receive FDA approved and non-approved PD1 inhibitors (i.e. pembrolizumab, nivolumab) or PDL1 inhibitor (i.e. atezolizumab, durvalumab) either single agent or as combination therapy with chemotherapy, or be eligible to receive FDA approved and non-approved tyrosine kinase inhibitors.
    1. The subject will be registered upon submission of the samples. When submitted on separate dates, the submission occurring later will be considered the date of registration

You CAN'T join if...

    1. Those subjects who are determined clinically unstable of the participation of this study as determined by the PI or treating physician will be excluded and asked to focus on their treatment.

Location

  • Chao Family Comprehensive Cancer Center University of California, Irvine accepting new patients
    Orange California 92868 United States

Lead Scientist at UC Irvine

  • Misako Nagasaka
    Associate Clinical Professor, Medicine, School of Medicine. Authored (or co-authored) 146 research publications

Details

Status
accepting new patients
Start Date
Completion Date
(estimated)
Sponsor
University of California, Irvine
ID
NCT06221800
Study Type
Observational
Participants
Expecting 82 study participants
Last Updated